Research Use (RUO) Recombinant Protein Market

The research use recombinant protein market is projected to reach USD 1.55 billion by 2031 from USD 1.11 billion in 2026, at a CAGR of 7.0% during the forecast period. Thermo Fisher Scientific Inc. (US), Bio-Techne (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity (US), BPS Bioscience, Inc. (US), Bio-Rad Laboratories, Inc. (US), Sartorius AG (Germany), Sino Biological, Inc. (China) and GenScript (China) are the key players in this market. These market players have adopted various approaches, including product launches, collaborations, acquisitions, agreements, and expansions, to enhance their market positions.

In June 2026, Merck KGaA entered into a definitive agreement to acquire Bio-Techne. The proposed transaction would add Bio-Techne’s recombinant protein portfolio, including cytokines and growth factors, to Merck KGaA’s Life Science business.

To know about the assumptions considered for the study download the pdf brochure

In May 2026, Miltenyi Biotec launched research-grade recombinant human IL-18, a pro-inflammatory cytokine optimized for cell-culture and functional-assay applications. The product supports NK-cell expansion and activation, cytokine-induced memory-like NK-cell generation, CAR-T research, and investigation of IL-18-mediated signaling pathways.

Thermo Fisher Scientific Inc. (US): Thermo Fisher Scientific offers a broad research use recombinant protein portfolio through its Gibco, Invitrogen, and PeproTech brands. Its offerings include cytokines, growth factors, chemokines, neurotrophins, proteases, enzymes, ligands, receptors, and selected viral proteins. These products support immune cell culture, stem cell and organoid research, cancer biology, disease modeling, cell signaling studies, and drug discovery. Gibco PeproTech proteins are manufactured under controlled in-house processes, while Gibco growth factors are designed to deliver reliable performance with cell culture media and assay models. The company’s broad selection of protein classes, species, and formulations, combined with technical documentation and application support, serves pharmaceutical and biotechnology companies, CROs, and academic research laboratories.

Bio-Techne (US): Bio-Techne participates in the research use recombinant protein market primarily through its R&D Systems brand. Its portfolio includes bioactive cytokines, growth factors, immune checkpoint proteins, receptors, enzymes, tagged proteins, fluorescent-labeled proteins, and animal-free recombinant proteins across multiple species. These products support immune cell culture, stem cell differentiation, organoid development, immuno-oncology research, protein interaction studies, antibody screening, and drug discovery. The company performs extensive in-house testing for biological activity, purity, endotoxin levels, stability, and lot-to-lot consistency to support reproducible research outcomes. Its broad product range and specialized protein formats are widely used by pharmaceutical and biotechnology companies, academic laboratories, and contract research organizations.

Merck KGaA (Germany): Merck offers research use recombinant proteins through its Life Science business and Sigma-Aldrich portfolio. Its offerings include recombinant cytokines, growth factors, chemokines, active enzymes, kinases, receptors, hormones, and other cell-signaling proteins. These products are used in mammalian and stem cell culture, proliferation and differentiation studies, inflammation research, cancer biology, angiogenesis studies, target identification, receptor-binding assays, and biochemical analysis. The portfolio includes proteins derived from multiple species and expression systems, supporting varied experimental requirements across basic and translational research. Merck’s broad life science distribution network, application resources, and complementary cell culture and protein-analysis products support adoption among academic institutes, pharmaceutical and biotechnology companies, and CROs.

Market Ranking

The research use recombinant protein market is competitive, with leading life science reagent suppliers differentiating through portfolio breadth, protein purity, biological activity, species coverage, and specialized formulations. Key players include Thermo Fisher Scientific Inc. (US), Bio-Techne Corporation (US), and Merck KGaA (Germany). Thermo Fisher Scientific offers recombinant cytokines, growth factors, chemokines, enzymes, receptors, and viral proteins through its Gibco, Invitrogen, and PeproTech brands, supporting cell culture, immunology, stem cell research, organoid development, and drug discovery. Bio-Techne Corporation, primarily through R&D Systems, strengthens its market position with validated bioactive proteins, animal-free proteins, carrier-free formats, immune checkpoint proteins, and species-specific reagents used in cell signaling, cancer research, protein interaction studies, and assay development. Merck KGaA contributes through its Sigma-Aldrich portfolio of cytokines, growth factors, kinases, enzymes, hormones, and receptors used in biochemical assays, target validation, cell-based research, and translational studies. Collectively, these companies improve access to high-purity recombinant proteins, support lot-to-lot consistency, and enable reproducible research across pharmaceutical and biotechnology companies, CROs, and academic institutions.

Related Reports:

Research Use Recombinant Protein Market by Product (Cytokines, Growth Factors), Product Formulation (Lyophilized, Liquid), Species (Human, Mouse), Host Cell (Mammalian, Yeast), Application (Cell Culture), End User, Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]